Stella Sarraf

Founder at Spinogenix, Inc.

Health Technology

Commercial Services

Profile

Stella Sarraf is the founder of Spinogenix, Inc. (founded in 2016) where she holds the titles of President, Chief Executive Officer & Director, and Amydis, Inc. (founded in 2013) where she holds the title of Chief Executive Officer & Director.

Stella Sarraf active positions

Companies	Position	Start
Spinogenix, Inc. Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA.	Founder	2015-12-31
Amydis, Inc. Amydis, Inc. Miscellaneous Commercial ServicesCommercial Services This technology allows physicians and researchers to explore the eye for a broad spectrum of diseases, which have previously required long-term clinical evaluation and invasive testing for definitive diagnosis. Amydis has a discovery platform and proprietary know-how that positions it as a first mover and leader in developing ocular tracers for human diseases. The American company was founded in 2013 by Stella Sarraf, who has been the CEO since then.	Founder	2012-12-31

All active positions of Stella Sarraf

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stella Sarraf's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Spinogenix, Inc. Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA.	Health Technology
Amydis, Inc. Amydis, Inc. Miscellaneous Commercial ServicesCommercial Services This technology allows physicians and researchers to explore the eye for a broad spectrum of diseases, which have previously required long-term clinical evaluation and invasive testing for definitive diagnosis. Amydis has a discovery platform and proprietary know-how that positions it as a first mover and leader in developing ocular tracers for human diseases. The American company was founded in 2013 by Stella Sarraf, who has been the CEO since then.	Commercial Services